AI Science Tracker

The Affiliated Guangzhou Panyu Central Hospital of Guangzhou Medical University

1 discovery from 2024

Discoveries

Machine-learning metabolomics prioritizes serum metabolites for SLE diagnosis and activity assessment

Targeted serum metabolomics compared 89 patients with systemic lupus erythematosus (SLE) and 44 healthy participants, identifying 146 differential metabolites. The authors combined statistical screening with seven machine-learning models to prioritize eight diagnostic biomarker candidates (reported AUCs above 0.95). Two additional metabolites, N-methyl-L-glutamic acid and L-2-aminobutyric acid, were evaluated by ELISA in a 90-patient SLE validation cohort and associated with SLE Disease Activity Index scores.

Technology: Seven machine-learning classification models applied to targeted serum metabolomics

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: The authors combined statistical screening with seven machine-learning models to prioritize eight diagnostic biomarker candidates (reported AUCs above 0.95).
  • Still unknown: This retrospective case-control study has modest cohorts and does not establish a clinically deployed test, causal SLE mechanism, or patient benefit. Reported diagnostic AUCs and SLEDAI associations require independent prospective replication; the validation cohort described in the abstract consists of SLE patients and does not by itself establish performance against a new external healthy/control population. The authors’ pathway interpretation is hypothesis-generating.
  • AI role: The study iteratively compared seven machine-learning models to select candidate metabolites for SLE classification and combined the selected features with statistical screening. N-methyl-L-glutamic acid and L-2-aminobutyric acid were subsequently assessed by ELISA in a patient validation cohort; the machine-learning analysis nominated candidates, while the assays supplied biological measurement follow-up.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/38710348/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 19 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.